There are 132 resources available
Recurrent/metastatic squamous cell carcinoma of the head and neck discussion
Presenter: Caroline Even
Session: ESMO Clinical Practice Guidelines 2
Resources:
Slides
Webcast
Recurrent/metastatic squamous cell carcinoma of the head and neck case presentation
Presenter: Cristina Gurizzan
Session: ESMO Clinical Practice Guidelines 2
Resources:
Slides
Webcast
932P - Survival in patients with relapsed/metastatic head and neck squamous cell carcinoma (HNSCC) treated with pembrolizumab or cetuximab-based therapy: A real-worlddata study with the TriNetX platform
Presenter: Lisardo Ugidos De La Varga
Session: Poster session 12
901P - Gut microbiome metagenomics and toxicity outcomes from chemoradiation therapy in head and neck squamous cell carcinoma
Presenter: Antoine Desilets
Session: Poster session 12
864P - Serial cell-free tumor DNA in prognosing survival in patients with head and neck squamous cell carcinoma treated with upfront surgery
Presenter: Grégoire Marret
Session: Poster session 12
890P - Real-world survival outcomes and survival risk factors in elderly patients with locally advanced squamous cell carcinoma of the head and neck
Presenter: Nabil Saba
Session: Poster session 12
858O - Minimal residual disease (MRD) diagnosed by a plasma tumor-agnostic circulating tumor DNA (ctDNA) assay after curative therapy in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN) predicts disease relapse and survival
Presenter: Natasha Honoré
Session: Proffered Paper session - Head and neck cancer
Resources:
Abstract
Slides
Webcast
1142P - Personalized decision making in cutaneous squamous cell carcinoma: Integrating a clinico-pathological model for absolute metastatic risk into the staging systems
Presenter: Marlies Wakkee
Session: Poster session 13
882P - Claudin-1 (CLDN1) expression in head and neck squamous cell carcinoma (HNSCC) patients
Presenter: Stefano Cavalieri
Session: Poster session 12
Novel combinations in the non-curative HNSCC setting
Presenter: Brigette Ma
Session: Immunotherapy for head and neck cancer: What, when and how long?
Resources:
Slides
Webcast